semaglutide pdufa Receives FDA Approval for Treatment of MASH Semaglutide | API DMFs |

For the first time ever, our clinical records will officially acknowledge that Type 2 diabetes can be driven into remission

Trial Registration ClinicalTrials.gov, identifier NCT03288740.

GLP-1 receptor (GLP-1R) agonists, like liraglutide, have shown analgesic effects by modulating pain hypersensitivity in animal models of inflammatory and neuropathic pain

GLP-1 medications have transformed weight management for millions, but access remains a barrier for many

Learn how to do it safely without impacting progress here.

Diabetes-specific nutritional supplements boost GLP-1 levels while offering complete, balanced nutrition for better diabetes management.